These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12461428)

  • 1. Diurnal variation of plasma protease inhibitor concentrations.
    Justesen US; Pedersen C
    AIDS; 2002 Dec; 16(18):2487-9. PubMed ID: 12461428
    [No Abstract]   [Full Text] [Related]  

  • 2. Simple and rapid high-performance liquid chromatographic method for nelfinavir, M8 nelfinavir metabolite, ritonavir and saquinavir assay in plasma.
    Janoly A; Bleyzac N; Favetta P; Gagneu MC; Bourhis Y; Coudray S; Oger I; Aulagner G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):155-60. PubMed ID: 12383491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of HIV-1 protease inhibitors into CSF and semen.
    Taylor S; Pereira A
    HIV Med; 2000 Jul; 1 Suppl 2():18-22. PubMed ID: 11737368
    [No Abstract]   [Full Text] [Related]  

  • 4. Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography.
    Hugen PW; Verweij-van Wissen CP; Burger DM; Wuis EW; Koopmans PP; Hekster YA
    J Chromatogr B Biomed Sci Appl; 1999 Apr; 727(1-2):139-49. PubMed ID: 10360433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of the new HIV protease inhibitor lopinavir (ABT 378) and of indinavir(1), amprenavir, saquinavir, ritonavir (ABT 538)(2) and nelfinavir(3) in human plasma by gradient HPLC.
    Kuschak D; Mauss S; Schmutz G; Gantke B
    Clin Lab; 2001; 47(9-10):471-7. PubMed ID: 11596909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interactions between HIV-1 protease inhibitors in rats: study on combinations of two kinds of HIV-1 protease inhibitors.
    Shibata N; Matsumura Y; Okamoto H; Kawaguchi Y; Ohtani A; Yoshikawa Y; Takada K
    J Pharm Pharmacol; 2000 Oct; 52(10):1239-46. PubMed ID: 11092568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro and in-vivo pharmacokinetic interactions of amprenavir, an HIV protease inhibitor, with other current HIV protease inhibitors in rats.
    Shibata N; Gao W; Okamoto H; Kishida T; Yoshikawa Y; Takada K
    J Pharm Pharmacol; 2002 Feb; 54(2):221-9. PubMed ID: 11848286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching antiretroviral therapy from an enzyme-inducing drug.
    Gyllensten K; Sönnerborg A; Ståhle L
    Ther Drug Monit; 2000 Oct; 22(5):637-8. PubMed ID: 11034274
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of ritonavir and saquinavir in a haemodialysis patient.
    Izzedine H; Launay-Vacher V; Legrand M; Aymard G; Deray G
    Nephron; 2001 Feb; 87(2):186-7. PubMed ID: 11244316
    [No Abstract]   [Full Text] [Related]  

  • 10. Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study.
    van Heeswijk RP; Veldkamp AI; Mulder JW; Meenhorst PL; Lange JM; Beijnen JH; Hoetelmans RM
    AIDS; 2000 Jun; 14(9):F103-10. PubMed ID: 10894270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients.
    Ford J; Boffito M; Maitland D; Hill A; Back D; Khoo S; Nelson M; Moyle G; Gazzard B; Pozniak A
    J Antimicrob Chemother; 2006 Nov; 58(5):1009-16. PubMed ID: 16984898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography.
    Bouley M; Briere C; Padoin C; Petitjean O; Tod M
    Ther Drug Monit; 2001 Feb; 23(1):56-60. PubMed ID: 11206045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography.
    Droste JA; Verweij-Van Wissen CP; Burger DM
    Ther Drug Monit; 2003 Jun; 25(3):393-9. PubMed ID: 12766571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of the five HIV-protease inhibitors: amprenavir, indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by solid-phase extraction and column liquid chromatography.
    Poirier JM; Radembino N; Robidou P; Jaillon P
    Ther Drug Monit; 2000 Aug; 22(4):465-73. PubMed ID: 10942189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of saquinavir in patients during protease inhibitor therapy with saquinavir alone or in combination with ritonavir or nelfinavir.
    Langmann P; Zilly M; Weissbrich B; Schlör C; Väth T; Richter E; Klinker H
    Eur J Med Res; 2000 Feb; 5(2):59-62. PubMed ID: 10720564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of simultaneous versus staggered dosing on pharmacokinetic interactions of protease inhibitors.
    Washington CB; Flexner C; Sheiner LB; Rosenkranz SL; Segal Y; Aberg JA; Blaschke TF;
    Clin Pharmacol Ther; 2003 May; 73(5):406-16. PubMed ID: 12732841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography.
    Sarasa-Nacenta M; López-Púa Y; Mallolas J; Blanco JL; Gatell JM; Carné X
    J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(2):325-32. PubMed ID: 11417878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy.
    Goujard C; Legrand M; Panhard X; Diquet B; Duval X; Peytavin G; Vincent I; Katlama C; Leport C; Bonnet B; Salmon-Céron D; Mentré F; Taburet AM;
    Clin Pharmacokinet; 2005; 44(12):1267-78. PubMed ID: 16372824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virus.
    Khaliq Y; Gallicano K; Venance S; Kravcik S; Cameron DW
    Clin Pharmacol Ther; 2000 Dec; 68(6):637-46. PubMed ID: 11180024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatography.
    Yamada H; Kotaki H; Nakamura T; Iwamoto A
    J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):85-9. PubMed ID: 11393736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.